Recurrence-free Survival as a Surrogate Endpoint for Overall Survival in Resectable Esophageal Cancer: Integrated Analysis of Individual Patient Data From Phase III Trials.

Saved in:
Bibliographic Details
Title: Recurrence-free Survival as a Surrogate Endpoint for Overall Survival in Resectable Esophageal Cancer: Integrated Analysis of Individual Patient Data From Phase III Trials.
Authors: Okui J; Department of Surgery, Keio University School of Medicine, Tokyo, Japan.; Department of Biostatistics, Keio University School of Medicine, Tokyo, Japan., Matsuda S; Department of Surgery, Keio University School of Medicine, Tokyo, Japan., Nagashima K; Biostatistics Unit, Clinical and Translational Research Center, Keio University Hospital, Tokyo, Japan., Sato Y; Department of Biostatistics, Keio University School of Medicine, Tokyo, Japan., Kawakubo H; Department of Surgery, Keio University School of Medicine, Tokyo, Japan., Ruhstaller T; Swiss Group for Clinical Cancer Research (SAKK), Switzerland.; University of Basel, Basel, Switzerland., Thuss-Patience P; Department of Hematology, Oncology and Cancer Immunology, Charité-University Medicine Berlin, Campus Virchow Klinikum, Berlin, Germany., Nilsson M; Division of Surgery and Oncology, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet and Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Sweden., Klevebro F; Division of Surgery and Oncology, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet and Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Sweden., Tan L; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China., Zhang S; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China., Aparicio T; Department of Digestive Oncology, Hôpital Saint-Louis, APHP, Université Paris Cité, Paris, France., Piessen G; University Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity, Plasticity and Resistance to Therapies, F-59000, Lille, France., van der Zijden C; Department of Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Mostert B; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Wijnhoven BPL; Department of Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Tsushima T; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan., Takeuchi H; Department of Surgery, Hamamatsu University School of Medicine, Shizuoka, Japan., Kato K; Department of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Kitagawa Y; Department of Surgery, Keio University School of Medicine, Tokyo, Japan.
Source: Annals of surgery [Ann Surg] 2025 Aug 25. Date of Electronic Publication: 2025 Aug 25.
Publication Type: Journal Article
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0372354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-1140 (Electronic) Linking ISSN: 00034932 NLM ISO Abbreviation: Ann Surg Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1528-1140
DOI:10.1097/SLA.0000000000006919